RAJKUMAR VENKATRAMANI to Sarcoma
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Sarcoma.
Connection Strength
1.347
-
Management and outcomes of chest wall rhabdomyosarcoma: A report from the Children's Oncology Group Soft Tissue Sarcoma Committee. Pediatr Blood Cancer. 2023 07; 70(7):e30357.
Score: 0.407
-
Soft Tissue and Visceral Organ Sarcomas With BCOR Alterations. J Pediatr Hematol Oncol. 2022 07 01; 44(5):195-200.
Score: 0.381
-
Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children's Oncology Group. Cancer. 2024 Jul 15; 130(14):2493-2502.
Score: 0.108
-
Outcomes After Preoperative Chemoradiation With or Without Pazopanib in Non-Rhabdomyosarcoma Soft Tissue Sarcoma: A Report From Children's Oncology Group and NRG Oncology. J Clin Oncol. 2023 11 01; 41(31):4842-4848.
Score: 0.104
-
Children's Oncology Group's 2023 blueprint for research: Soft tissue sarcomas. Pediatr Blood Cancer. 2023 09; 70 Suppl 6:e30556.
Score: 0.103
-
Neoadjuvant pazopanib in nonrhabdomyosarcoma soft tissue sarcomas (ARST1321): A report of major wound complications from the Children's Oncology Group and NRG Oncology. J Surg Oncol. 2023 Apr; 127(5):871-881.
Score: 0.100
-
Pediatric liposarcoma: A case series and literature review. Pediatr Blood Cancer. 2021 12; 68(12):e29327.
Score: 0.091
-
Advances in therapy for pediatric sarcomas. Curr Oncol Rep. 2014; 16(8):395.
Score: 0.053